| Current IVIG coreSPC indication and dosing: |
| Guillain–Barré syndrome. |
| 0.4 g/kg/day over 5 days. |
| No current SCIG coreSPC indication or dosing under discussion. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.